Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells

Thrombosis Research

Volumn 123, Issue 5, 2009, Pages 780-784

  Roth, Georg A ^a,b   Aumayr, Klaus ^c   Giacona, Mary Beth ^c   Papapanou, Panos N ^c   Schmidt, Ann Marie ^a   Lalla, Evanthia ^c  

^a College of Physicians and Surgeons ^*  (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c New York Presbyterian Hospital   (United States)

Author keywords

Atherosclerosis; Infection; P. gingivalis; Periodontitis; Smooth muscle cell; Thrombosis

Indexed keywords

ANTIGEN; THROMBOPLASTIN; TISSUE FACTOR ANTIGEN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; ATHEROTHROMBOSIS; BACTERIAL INFECTION; BACTERIAL STRAIN; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PORPHYROMONAS GINGIVALIS INFECTION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOSIS;

AORTA; BACTERIAL ADHESION; HUMANS; LIPOPROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PORPHYROMONAS GINGIVALIS; THROMBOPLASTIN; THROMBOSIS;

EID: 60449110889     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.07.008     Document Type: Article

References (40)

1. Hedin U., Roy J., and Tran P.K. Control of smooth muscle cell proliferation in vascular disease. Curr Opin Lipidol 15 (2004) 559-565
2. Levi M., van der Poll T., and Buller H.R. Bidirectional relation between inflammation and coagulation. Circulation 109 (2004) 2698-2704
3. Elkind M.S., and Cole J.W. Do common infections cause stroke. Semin Neurol 26 88-99 (2006)
4. Papapanou P.N. Periodontal diseases: epidemiology. Ann Periodontol 1 (1996) 1-36
5. Beck J.D., and Offenbacher S. The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol 6 (2001) 9-15
6. Desvarieux M., Demmer R.T., Rundek T., Boden-Albala B., Jacobs Jr. D.R., Sacco R.L., et al. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111 (2005) 576-582
7. Seinost G., Wimmer G., Skerget M., Thaller E., Brodmann M., Gasser R., et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 149 (2005) 1050-1054
8. Behle J.H., and Papapanou P.N. Periodontal infections and atherosclerotic vascular disease: an update. Int Dent J 56 (2006) 256-262
9. Epstein S.E. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 90 (2002) 2-4
10. Tonetti M.S., D'Aiuto F., Nibali L., Donald A., Storry C., Parkar M., et al. Treatment of periodontitis and endothelial function. N Engl J Med 356 (2007) 911-920
11. Haraszthy V.I., Zambon J.J., Trevisan M., Zeid M., and Genco R.J. Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71 (2000) 1554-1560
12. Kozarov E.V., Dorn B.R., Shelburne C.E., Dunn Jr. W.A., and Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 25 (2005) e17-e18
13. Kinane D.F., Riggio M.P., Walker K.F., MacKenzie D., and Shearer B. Bacteraemia following periodontal procedures. J Clin Periodontol 32 (2005) 708-713
14. Giacona M.B., Papapanou P.N., Lamster I.B., Rong L.L., D'Agati V.D., Schmidt A.M., et al. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol Lett 241 (2004) 95-101
15. Dorn B.R., Dunn Jr. W.A., and Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 67 (1999) 5792-5798
16. Deshpande R.G., Khan M.B., and Genco C.A. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 66 (1998) 5337-5343
17. Lalla E., Lamster I.B., Hofmann M.A., Bucciarelli L., Jerud A.P., Tucker S., et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 23 (2003) 1405-1411
18. Gibson III F.C., Hong C., Chou H.H., Yumoto H., Chen J., Lien E., et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109 (2004) 2801-2806
19. Brodala N., Merricks E.P., Bellinger D.A., Damrongsri D., Offenbacher S., Beck J., et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 25 (2005) 1446-1451
20. Roth G.A., Moser B., Huang S.J., Brandt J.S., Huang Y., Papapanou P.N., et al. Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromb Haemost 4 (2006) 2256-2261
21. Roth G.A., Moser B., Roth-Walter F., Giacona M.B., Harja E., Papapanou P.N., et al. Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 190 (2007) 271-281
22. Malek R., Fisher J.G., Caleca A., Stinson M., van Oss C.J., Lee J.Y., et al. Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol 176 (1994) 1052-1059
23. Camera M., Giesen P.L., Fallon J., Aufiero B.M., Taubman M., Tremoli E., et al. Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. Arterioscler Thromb Vasc Biol 19 (1999) 531-537
24. Steffel J., Akhmedov A., Greutert H., Luscher T.F., and Tanner F.C. Histamine induces tissue factor expression: implications for acute coronary syndromes. Circulation 112 (2005) 341-349
25. Darveau R.P., Arbabi S., Garcia I., Bainbridge B., and Maier R.V. Porphyromonas gingivalis lipopolysaccharide is both agonist and antagonist for p38 mitogen-activated protein kinase activation. Infect Immun 70 (2002) 1867-1873
26. Belanger M., Rodrigues P.H., Dunn Jr. W.A., and Progulske-Fox A. Autophagy: a highway for Porphyromonas gingivalis in endothelial cells. Autophagy 2 (2006) 165-170
27. Madianos P.N., Papapanou P.N., Nannmark U., Dahlen G., and Sandros J. Porphyromonas gingivalis FDC381 multiplies and persists within human oral epithelial cells in vitro. Infect Immun 64 (1996) 660-664
28. Dorn B.R., Dunn Jr. W.A., and Progulske-Fox A. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect Immun 69 (2001) 5698-5708
29. Roth G.A., Ankersmit H.J., Brown V.B., Papapanou P.N., Schmidt A.M., and Lalla E. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol Lett 272 (2007) 106-113
30. Viles-Gonzalez J.F., Fuster V., and Badimon J.J. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 25 (2004) 1197-1207
31. Steffel J., Luscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113 (2006) 722-731
32. Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol 22 (2002) 539-548
33. Broze Jr. G.J., Warren L.A., Novotny W.F., Higuchi D.A., Girard J.J., and Miletich J.P. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 71 (1988) 335-343
34. Crawley J., Lupu F., Westmuckett A.D., Severs N.J., Kakkar V.V., and Lupu C. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 20 (2000) 1362-1373
35. Caplice N.M., Mueske C.S., Kleppe L.S., Peterson T.E., Broze Jr. G.J., and Simari R.D. Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. Circ Res 83 (1998) 1264-1270
36. Ragni M., Golino P., Cirillo P., Scognamiglio A., Piro O., Esposito N., et al. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury. Circulation 102 (2000) 113-117
37. Nishida T., Ueno H., Atsuchi N., Kawano R., Asada Y., Nakahara Y., et al. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit. Circ Res 84 (1999) 1446-1452
38. Zoldhelyi P., Chen Z.Q., Shelat H.S., McNatt J.M., and Willerson J.T. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci U S A 98 (2001) 4078-4083
39. Hamuro T., Kamikubo Y., Nakahara Y., Miyamoto S., and Funatsu A. Human recombinant tissue factor pathway inhibitor induces apoptosis in cultured human endothelial cells. FEBS Lett 421 (1998) 197-202
40. Esmon C.T. Role of coagulation inhibitors in inflammation. Thromb Haemost 86 (2001) 51-56